Companies: 10,795·Total market cap: $144.5T
BeOne Medicines Ltd.

BeOne Medicines Ltd.

ONCNASDAQHealthcare● Active
$270.10
$-9.83(-3.51%)
Market Cap$28.9B
P/E Ratio—
52W High$385.22
52W Low$239.25
SEC Filings

BeOne Medicines Ltd. (ONC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001651308 · ONC · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
4
Latest Form
2026-06-03
Most Recent
2016
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001651308 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-26
Fiscal Year End
Feb 26, 2026
Accession No.
0001628280-26-011946
Primary Document
bgne-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001651308 · Accession 0001628280-26-011946

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-06
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-15Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
3/AInitial Statement of Beneficial Ownership (Amended)
FORM 3/A
2026-05-15
View
8-KCurrent Report
8-K
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
S-3ASRS-3ASR
S-3ASR
2026-05-06
View
S-3ASRS-3ASR
FORM S-3ASR
2026-05-06
View
10-QQuarterly Report
10-Q
2026-05-06
View
8-KCurrent Report
8-K
2026-05-06
View
ARSARS
ARS
2026-04-28
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-28
View
DEF 14AProxy Statement
FORM DEF 14A
2026-04-28
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-16
View
PRE 14APRE 14A
PRE 14A
2026-04-16
View
8-KCurrent Report
8-K
2026-04-14
View
10-KAnnual Report
10-K
2026-02-26
View
8-KCurrent Report
8-K
2026-02-26
View
Showing 1–15 of 463 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001651308  |  Exchange: NASDAQ · Healthcare

BeOne Medicines Ltd. (NASDAQ: ONC) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001651308, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BeOne Medicines Ltd.'s most comprehensive regulatory disclosure. The most recent BeOne Medicines Ltd. 10-K was filed on 2026-02-26 for fiscal year ending 2026. Historical ONC 10-K annual reports are available from 2017 through 2026.

Investors researching BeOne Medicines Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
HUM SEC Filings →A SEC Filings →ALC SEC Filings →NTRA SEC Filings →IQV SEC Filings →GEHC SEC Filings →RMD SEC Filings →PHG SEC Filings →
→ ONC Financials→ ONC Earnings→ ONC Insider Trades

Frequently Asked Questions

ONC SEC Filings · 8 questions

BeOne Medicines Ltd. (ONC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. BeOne Medicines Ltd.'s CIK is 0001651308.

ONC SEC filingsBeOne Medicines Ltd. SEC documentsfind ONC 10-K